Table 2 Frequency of reporting symptoms of respiratory tract infection last week by characteristics of 6414 middle-aged and elderly adults taking part in the Tromsø 6 survey
Symptoms of RTI last week | Days since start of symptoms | Symptoms of RTI last week that started within the previous 7 days | ||||||
|---|---|---|---|---|---|---|---|---|
n | % | p-value | median | p-value | n | % | p-value | |
All (n = 6414) | 798 | 12 | 8 | 340 | 5.3 | |||
Gender | ||||||||
Male (n = 2754) | 350 | 13 | 0.6 | 8 | 0.6 | 149 | 5.4 | 0.7 |
Female (n = 3660) | 448 | 12 | 8 | 191 | 5.2 | |||
Age | ||||||||
<55 years (n = 1059) | 141 | 13 | 0.001# | 7 | 0.03£ | 79 | 7.5 | <0.001# |
55-64 years (n = 2656) | 354 | 13 | 9 | 138 | 5.2 | |||
65-74 years (n = 1752) | 230 | 13 | 9 | 217 | 5.5 | |||
≥ 75 Years (n = 947) | 947 | 8 | 14 | 123 | 2.7 | |||
Smoking (n = 6323) | ||||||||
Current (n = 1158) | 214 | 19 | <0.001# | 11 | 0.01£ | 76 | 6.6 | 0.7 |
Previous (n = 2955) | 334 | 11 | 8 | 132 | 4.5 | |||
Never (n = 2210) | 240 | 11 | 7 | 126 | 5.7 | |||
Season | ||||||||
Winter (November-April) (n = 3128) | 425 | 14 | 0.007 | 9 | 0.2 | 175 | 5.6 | 0.3 |
Summer (May-October) (n = 3286) | 373 | 11 | 8 | 165 | 5.0 | |||
Self-reported disease & | ||||||||
Asthma, not COPD (n = 457) | 69 | 15 | 0.07 | 11 | 0.5 | 28 | 6.1 | 0.4 |
COPD, not asthma (n = 172) | 25 | 15 | 0.4 | 14 | 0.09 | 6 | 3.5 | 0.3 |
Both asthma and COPD (n = 141) | 22 | 16 | 0.3 | 12 | 0.5 | 9 | 6.4 | 0.6 |
Neither asthma nor COPD (n = 5578) | 679 | 12 | 0.09 | 8 | 0.1 | 296 | 5.3 | 1.0 |
Cardiovascular disease (n = 1154) | 134 | 12 | 0.3 | 12 | 0.02 | 47 | 4.1 | 0.04 |
Self-rated health (n = 6353) | ||||||||
Good/exellent (n = 3949) | 449 | 11 | 0.001# | 8 | 0.01£ | 207 | 5.2 | 0.9 |
Neither good nor bad (n = 2057) | 288 | 14 | 10 | 109 | 5.3 | |||
Bad/very bad (n = 347) | 53 | 15 | 14 | 19 | 5.5 | |||
Lung function (n = 6305) | ||||||||
Normal/restrictive (n = 4881) | 567 | 12 | <0.001# | 8 | <0.001£ | 267 | 5.5 | 0.2# |
GOLD 1 (n = 643) | 80 | 12 | 11 | 26 | 4.0 | |||
GOLD 2–4 (n = 781) | 134 | 17 | 13 | 31 | 4.6 | |||
Self-reported asthma or COPD and lung function combined (n = 6305) & | ||||||||
Asthma or COPD not reported, FEV1/FVC ≥ 0.7 (n = 4436) | 511 | 12 | 0.001 | 8 | 0.009 | 235 | 5.3 | 0.7 |
Asthma or COPD reported, FEV1/FVC ≥ 0.7 (n = 445) | 56 | 13 | 0.9 | 7 | 0.09 | 32 | 7.2 | 0.05 |
Asthma or COPD reported, FEV1/FVC <0.7 (n = 380) | 61 | 16 | 0.03 | 14 | <0.001 | 11 | 2.9 | 0.04 |
Asthma or COPD not reported but GOLD 1 spirometry (n = 559) | 69 | 12 | 1.0 | 9 | 0.9 | 25 | 4.5 | 0.4 |
but GOLD 2–4 spirometry (n = 485) | 84 | 17 | 0.001 | 12 | 0.04 | 26 | 5.4 | 0.9 |